Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FAK Inhibitors As Promising Anticancer Targets: Present and Future Directions
Muhamad Mustafa, Amer Ali Abd El‐Hafeez, Dalia A Abdelhafeez, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 18, pp. 1559-1590
Open Access | Times Cited: 15

Showing 15 citing articles:

Roles and inhibitors of FAK in cancer: current advances and future directions
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 19
Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders
Ming Yang, Hua Xiang, Guoshun Luo
Biochemical Pharmacology (2024) Vol. 224, pp. 116246-116246
Closed Access | Times Cited: 8
The Development of FAK Inhibitors: A Five-Year Update
Andrea Spallarossa, Bruno Tasso, Eleonora Russo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6381-6381
Open Access | Times Cited: 33
Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 271-289
Closed Access | Times Cited: 4
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: Synthesis, mechanistic Insights and promising antitumor and safety profile
Daniela Carbone, Camilla Pecoraro, Fabio Scianò, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile
Camilla Pecoraro, Daniela Carbone, Fabio Scianò, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 10, pp. 1278-1294
Open Access | Times Cited: 2
Molecular Docking, Molecular Dynamics Simulations, and Free Energy Calculation Insights into the Binding Mechanism between VS-4718 and Focal Adhesion Kinase
Mingsong Shi, Tao Chen, Siping Wei, et al.
ACS Omega (2022) Vol. 7, Iss. 36, pp. 32442-32456
Open Access | Times Cited: 14
Computational insights into allosteric inhibition of focal adhesion kinase: A combined pharmacophore modeling and molecular dynamics approach
Vikas Kumar, Pooja Singh, Shraddha Parate, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 130, pp. 108789-108789
Closed Access | Times Cited: 1
Precision Targeting Strategies in Cancer Therapy: Focusing on Synthetic Lethality with FAK Inhibition
Pınar Si̇yah
Research Square (Research Square) (2024)
Open Access
Advanced Computational Pipeline for FAK Inhibitor Discovery: Combining Multiple Docking Methods with MD and QSAR for Cancer Therapy
Pınar Si̇yah
Computation (2024) Vol. 12, Iss. 11, pp. 222-222
Open Access
Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation
Jiaying Wen, Li-Ting Qin, Gang Chen, et al.
Disease Markers (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 3
The angiogenic genes predict prognosis and immune characteristics in esophageal squamous cell carcinoma: Evidence from multi-omics and experimental verification
Shuaiyuan Wang, Yinghao Liang, Jiaxin Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
FAK inhibitor PF-562271 inhibits the migration and proliferation of high-grade serous ovarian cancer cells through FAK and FAK mediated cell cycle arrest
Qionghui Pan, Qingyu Wang, Tianshu Zhao, et al.
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 1
Identification of defactinib derivatives targeting focal adhesion kinase using ensemble docking, molecular dynamics simulations and binding free energy calculations
Chuan Guo, Qinxuan Li, Jiujia Xiao, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 18, pp. 8654-8670
Open Access | Times Cited: 2
Probing the Expression of ASAP1 and FAK in nonsmall cell lung cancer and their clinicopathological significance
Qixian Zheng, Ningjing Guo, Qiong Luo, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top